Colour enhancement - PsychonautWiki
Open main menu

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:2 tabs DOB - My DOB Nightmare
5-MeO-DiBF
Mescaline
2C-P
4-HO-DPT
MiPT
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
DiPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
LSM-775
4-HO-DiPT
Efavirenz
4-FA
AL-LAD
PRO-LAD
Ayahuasca
MDMA
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
2C-T-7
MDAI
2C-B
4-AcO-DMT
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Cannabis
5-MeO-MiPT
MDEA
25B-NBOH
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
2C-H
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
25B-NBOMe
5-MeO-DiPT
Selective serotonin reuptake inhibitor
6-APDB
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
25I-NBOH
4-HO-MET
Experience:300µg LSD - Togetherness and the Silent Dusk
Omberacetam
Methallylescaline
Coluracetam
Βk-2C-B
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Amanita muscaria
LSA
ETH-LAD
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
MET
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
25D-NBOMe
4-AcO-MET
Bromo-DragonFLY
Experience:1050 µg 1cP-LSD - The matrix
DOI
3-MeO-PCE
EPT
Escaline
DOM
2C-T-21
GABAergic hallucinogens
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
2C-E
Phenethylamine (compound)
Pramiracetam
4-AcO-MiPT
Phenylpiracetam
PARGY-LAD
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Ibogaine
1P-LSD
4-HO-MiPT
ALD-52
Bufotenin
2C-T-2
LSZ
25I-NBOMe
Pregabalin
4-HO-EPT
DET
THJ-2201
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:250mg DXM - DXM Itch and Trip Report
25C-NBOH
TMA-2
5-MeO-DALT
Experience:40mg - Brothermind and the Forest's Hand
Piracetam
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:BK-2C-B - Various experiences
MiPLA
Experience:~150mg MDA(oral) - a case of mistaken identity
4-AcO-DET
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
3C-E
6-APB
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
25C-NBOMe
Enhancement of colour rose.jpgRose by Chelsea Morgan
DOB
4-HO-MPT
MPT
ΑMT
Paradise island by Xanny.jpgParadise island by Subsentience
25N-NBOMe
Experience:337mg DMT fumarate - A Day With DMT
Allylescaline
Experience:800 seeds LSA - My First Trip Ever
Experience:4-HO-MiPT / A care free psychedelic getaway
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
TMA-6
2C-D
Chur City in Switzerland.jpgChur, Switzerland by Naps284
4-AcO-DiPT
Memantine
MDA
Chameleon.jpgChameleon by Anonymous.
Psilocybin mushrooms
5F-PB-22
3-MMC
DPT
2C-B-FLY
5-Hydroxytryptophan
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
JWH-018
Psilocin
THJ-018
DMT
Tree.jpgJapanese Garden by Anonymous
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Proscaline
1P-ETH-LAD
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
JWH-073
Experience:4x 200ug tabs - You do not need to understand
Experience:3-MeO-PCP - Extreme psychosis
LSD
Oxiracetam
4-HO-DET
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:120mg - Garden of The Gods
2C-C
2C-I
Experience:4-AcO-DMT + 200mg Pill
Experience:1mg 25c-NBOMe - Experiment in my room
DOC
Aniracetam
1B-LSD
Experience:4.5g - The Grand Introduction to Beauty and Fear

Contents

Psychoactive substances

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.